Skip to Main Content

As anger mounts over the cost of prescription medicines, a new analysis finds that brand-name drug makers increased their list prices by 5.5 percent in last year’s fourth quarter, but after subtracting various allowances, their net pricing fell by 1.1 percent.

And the average concession off the list price, which is also known as the wholesale price, was 41 percent, according to Sector & Sovereign Research, which tracks the pharmaceutical industry. These concessions included rebates paid to pharmacy benefit managers, allowances given to wholesalers, fees paid to retailers, provisions for returned goods, and the cost of any copay card or coupon programs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED